Edition:
United Kingdom

People: OncoTherapy Science Inc (4564.T)

4564.T on Tokyo Stock Exchange

102JPY
13 Sep 2019
Change (% chg)

¥-1 (-0.97%)
Prev Close
¥103
Open
¥101
Day's High
¥102
Day's Low
¥101
Volume
498,200
Avg. Vol
732,803
52-wk High
¥175
52-wk Low
¥100

Fujiya, Kyoko 

Ms. Kyoko Fujiya was named President and Representative Director in OncoTherapy Science, Inc., as well as President and Representative Director of a subsidiary, Cancer Precision Medicine, Inc., effective January 23, 2019. Her previous titles include Executive Officer and Senior Director of Business in the Company. She used to work for GE Healthcare Japan Corporation and another company. She obtained her Bachelor's degree in English from Shibuya Institute of Foreign Languages in March 1986, and her Bachelor's degree in Management Information from SANNO UNIVERSITY in September 2003.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --